The prevalence of Chemotherapy Induced Peripheral Neuropathy (CIPN) is as high as 68% of all patients and 30% even six months after chemotherapy. It is important to understand the cause and find ways to deal with the pain. Caregivers should not dismiss the pain. Dr. Shital Raval explains CIPN, the symptoms and approaches for management of CIPN.
When the nerves outside of the brain and spinal cord are affected or damaged, it causes a condition called peripheral neuropathy. While…

This new class of drugs unleashes the body's immune system to fight tumors. This seems to solve a century-old mystery of how cancerous cells manage to evade the body's immune system. The drug which Merck will sell under the name of Keytruda was approved by patients with advanced melanoma who have exhausted other therapies.
Changed
08/Sep/2014
Community
Condition